Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchmots-cdiabetic retinopathymitochondrial peptides

MOTS-c reported to protect retinal blood vessels in diabetes model

The mitochondrial-derived peptide is credited with limiting diabetic damage to retinal microvasculature in the reported work.

PR
By Priya Raman · Science Reporter
Oct 11 01:03 ETSource: Bioengineer.org

The wire

  1. 01Researchers report that the mitochondrial-derived peptide MOTS-c shields retinal blood vessels from damage associated with diabetes.
  2. 02MOTS-c is tracked closely by readers following mitochondrial and longevity peptides, and diabetic retinopathy would be a new indication direction for it.
  3. 03The report is preclinical; dose, model and endpoint details should be read in the underlying paper before drawing any clinical inference.

From the source

Tiny Mitochondrial Peptide MOTS-c Shields Retinal Blood Vessels From Diabetes Damage

Read at bioengineer.org
PeptiPrescribed peptides from $99/moSee all →